Brainomix’s Post

💥 6 Key Pharma & Digital Health Developments this month>> 💊Daewoong Pharmaceutical is expanding its AI enabled mobiCARE wearable ECG patch into health check up centers in Korea. The patch allows continuous heart monitoring for up to nine days, aiding in detecting hidden heart conditions, enhancing early diagnosis and access to the right treatment 💊Takeda is teaming up with nference to identify AI enabled personalised treatment approaches for patients with inflammatory bowel disease (IBD) The goal is to unlock insights and enable more precise and targeted interventions for the disease, using electronic health record analysis to identify patients who could benefit from specific treatments. 💊AstraZeneca and Bayer participate in $80M Huma investment round. Huma are launching 'Shopify for Digital Health’ a no-code framework designed to allow developers to build and launch custom digital health apps using an array of 'drag-and-drop' widgets and templates 💊Bayer partners with Rad AI to integrate generative AI tools into the Calantic Digital Solution, aiming to streamline radiology workflows and improve efficiency for doctors and hospitals 💊Boehringer Ingelheim expands partnership Brainomix, using AI to improve interstitial lung disease (ILD) care in the US. They will use Brainomix’ 360 e-Lung software (FDA approved in May) to help diagnose and assess ILD patients via CT scans 💊And finally Boehringer Ingelheim will offer its 'Humira rival' at a 92% discount on the digital healthcare platform GoodRx. 👇Link to all articles in comments #DigitalHealth #AI